InsiderClue
Stocks · Health care · Biological Products, (No Diagnostic Substances)

Kyverna Therapeutics, Inc.

KYTX Clue Score44
United States Fiscal year ends December CIK 0001994702 Results filed 11 Aug 2026
Add to watchlist

What the insiders did Net buying

Individual transactions

7
Insider
Date
Role
Action
Shares
Price
Amount
Westlake BioPartners Opportunity Fund I, L.P.
18 Dec 2025
10% owner
Buy indirect
133,333
$7.50
$1,000.00K
Beth C Seidenberg
18 Dec 2025
Director
Buy indirect
133,333
$7.50
$1,000.00K
Northpond Ventures III GP, LLC
12 Feb 2024
Former 10% Owner
Buy indirect
450,000
$22.00
$9.90M
Gilead Sciences, Inc.
12 Feb 2024
10% owner
Buy
910,000
$22.00
$20.02M
Bain Capital Life Sciences Investors, LLC
12 Feb 2024
10% owner
Buy indirect
450,000
$22.00
$9.90M
Vida Ventures, LLC
12 Feb 2024
10% owner
Buy indirect
583
$22.00
$12.83K
Vida Ventures, LLC
12 Feb 2024
10% owner
Buy indirect
252,553
$22.00
$5.56M
Show all 11 transactions →

What was left out

Form 4 filings counted 41
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 5
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 1
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 27,194,442
History held since 12 Feb 2024